Published in Oxid Med Cell Longev on April 29, 2015
New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis. Oxid Med Cell Longev (2016) 0.75
The increased level of COX-dependent arachidonic acid metabolism in blood platelets from secondary progressive multiple sclerosis patients. Mol Cell Biochem (2016) 0.75
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med (2002) 8.33
Proteinase-activated receptors. Pharmacol Rev (2001) 5.02
Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell (1998) 4.18
Platelets in inflammation and atherogenesis. J Clin Invest (2005) 4.10
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature (2008) 3.48
The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol (2005) 2.96
Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol (2010) 2.43
Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol (2012) 2.32
Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol (1994) 1.95
Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res (2012) 1.85
Mitochondrial changes within axons in multiple sclerosis. Brain (2009) 1.81
Reactive oxygen species: players in the platelet game. Arterioscler Thromb Vasc Biol (2004) 1.38
Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol (2009) 1.29
Evidence of platelet activation in multiple sclerosis. J Neuroinflammation (2008) 1.15
Platelets and inflammation. Anat Embryol (Berl) (1997) 1.15
Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules. Mol Aspects Med (1999) 1.12
Role of platelets in neuroinflammation: a wide-angle perspective. J Neuroinflammation (2010) 1.11
Chronic progressive multiple sclerosis - pathogenesis of neurodegeneration and therapeutic strategies. Curr Neuropharmacol (2010) 1.10
Progressive multiple sclerosis. Semin Immunopathol (2009) 1.00
Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis. J Neuroimmunol (1999) 0.98
Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review. Mult Scler (2013) 0.95
Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis. Clin Biochem (2011) 0.95
Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis. J Neuroimmunol (2005) 0.94
Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment. Autoimmune Dis (2010) 0.93
Rapid photometric method for estimation of platelet count in blood plasma or platelet suspension. Thromb Res (1989) 0.93
Multiple sclerosis. Adv Exp Med Biol (2012) 0.92
Heterogeneity in multiple sclerosis: scratching the surface of a complex disease. Autoimmune Dis (2010) 0.92
Amino acid sequence of the carboxy-terminal cyanogen bromide peptide of the human fibrinogen beta-chain: homology with the corresponding gamma-chain peptide and presence in fragment D. Biochim Biophys Acta (1975) 0.91
Direct contact of platelets and their released products exert different effects on human dendritic cell maturation. BMC Immunol (2008) 0.88
Oxygen radical generation in human platelets: dependence on 12-lipoxygenase activity and on the glutathione cycle. Int Arch Allergy Appl Immunol (1990) 0.87
Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis. PLoS One (2013) 0.87
Multiple sclerosis and risk of venous thromboembolism: a population-based cohort study. Neuroepidemiology (2012) 0.85
Antioxidant and antiaggregatory effects of an extract from Conyza canadensis on blood platelets in vitro. Platelets (2006) 0.84
Effect of cisplatin on lipid peroxidation in pig blood platelets. Cytobios (1992) 0.82
[Oxidative stress in multiple sclerosis]. Pol Merkur Lekarski (2009) 0.79
Multiple sclerosis. Glob Adv Health Med (2013) 0.78
Response of blood platelets to beta-glucan from Saccharomyces cerevisiae. Platelets (2010) 0.78
[Molecular network analysis of multiple sclerosis brain lesion proteome]. Nihon Rinsho Meneki Gakkai Kaishi (2010) 0.77
Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases. Oxid Med Cell Longev (2014) 0.88
Platelets miRNA as a Prediction Marker of Thrombotic Episodes. Dis Markers (2016) 0.78
Poststroke depression as a factor adversely affecting the level of oxidative damage to plasma proteins during a brain stroke. Oxid Med Cell Longev (2015) 0.75